CPCM
CYTO

Clifton Park Capital Management’s Altamira Therapeutics Ltd CYTO Stock Holding History

Clifton Park Capital Management’s Portfolio CYTO Stock Details CYTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$7.6M Hold
19
– – 0.86% 14
2015
Q3 		$5.53M Sell
19
-1
-5% -$383K 0.49% 16
2015
Q2 		$7.73M Sell
20
-1
-5% -$415K 0.56% 17
2015
Q1 		$8.88M Hold
21
– – 0.54% 21
2014
Q4 		$6.5M Buy
+21
New +$7.41M 0.39% 23

Other funds holding CYTO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BAMS
Bellevue Asset Management (Switzerland) Kuesnacht, Switzerland $656M AUM 11.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
HCM
Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $27.4B AUM 24.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Clifton Park Capital Management's CYTO Position: Q4 2015 in Review

Clifton Park Capital Management held its Altamira Therapeutics Ltd (CYTO) position steady in Q4 2015 at 19 shares worth $7.6M. The position accounts for 0.86% of the portfolio, ranked #14.

Clifton Park Capital Management first reported a position in CYTO in Q4 2014 and has held it in 5 quarters since. The position peaked at $8.88M in Q1 2015. 10 funds tracked by Wall St. Rank hold CYTO as of Q4 2015.

  • Clifton Park Capital Management held 19 shares of Altamira Therapeutics Ltd worth $7.6M as of Q4 2015.
  • Clifton Park Capital Management left its Altamira Therapeutics Ltd share count unchanged in Q4 2015.
  • Altamira Therapeutics Ltd made up 0.86% of Clifton Park Capital Management's portfolio in Q4 2015, its #14 holding.
  • Clifton Park Capital Management first reported a position in Altamira Therapeutics Ltd in Q4 2014 and has held it in 5 quarters since.
  • Clifton Park Capital Management's Altamira Therapeutics Ltd position peaked at $8.88M in Q1 2015.
  • 10 funds tracked by Wall St. Rank held Altamira Therapeutics Ltd as of Q4 2015.

Based on Clifton Park Capital Management's 13F filing for Q4 2015, filed 10 Feb 2016.